RAPID TREND SHIFT IN RADIOLOGY TECHNOLOGY AND ACCESSIBILITY
With
Dr Mansoor Parker,
Diagnostic & Interventional Radiologist & Founding Partner,
Quantum Radiology, Sydney &
Board Member,
Australian Diagnostic Imaging Association
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | October 2025
Dr Mansoor Parker obtained his medical degree from the University of Tasmania. He then completed his specialist radiology training at Nepean Hospital, Sydney with subspecialty interests in Interventional Radiology and Pain Management, Musculoskeletal, Cardiac and Abdominal Imaging. Dr Parker is a qualified specialist since 2005 and is a member of the Royal Australian and New Zealand College of Radiologists and the exclusive Australasian Musculoskeletal Imaging Group (AMSIG) as well as the Interventional Radiology Society of Australasia (IRSA).
Dr Parker has completed his Masters Training in Cardiac CT (Level B) and CT Colonography. He has also completed CT Colonography and Cardiac CT Angiography Accreditation obtaining Level 2 Society of Cardiovascular CT (CTCA), the highest level available in Australia. He sits on the board of directors of Australian Diagnostic Imaging Associated (ADIA) and is a committee member of the Medical Imaging Accreditation Scheme Advisory Committee (MIASAC) as part of the Australian Commission on Safety and Quality in Health Care.
Dr Mansoor Parker has been involved in developing CT Colonography software used on many CT machines today. Dr Parker is the founding partner of Quantum Radiology (founded in 2005) and serves in the position of the Chair of the Doctors Management Committee (DMC) at the Quantum Medscan Radiology Group
Source: Supplied
-
Pharmacist Prescribing Model gets further support from state health
A full scope pharmacist prescriber model allows pharmacists to independently prescribe medicines within their professional competence, without requiring prior doctor authorisation. It extends pharmacists’ role beyond dispensing to include assessment, diagnosis of minor and chronic conditions, initiation and modification of therapy, and ongoing patient monitoring. This model integrates pharmacists into primary care teams, aiming to improve timely access to treatment, reduce pressure on general practitioners, and enhance continuity of care. Pharmacists use their clinical knowledge, patient records, and collaborative pathways to ensure safe prescribing. The model emphasises training, regulation, and accountability to maintain high standards of patient safety.
-
Victorian social prescribing program underway
n Part 2 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people involved in the Connect Local program under the Connecting Communities to Care 4 year program. The free program for over 65’s promotes wellbeing through social connection and is underway in the Glen Eira community in Melbourne.
– Deidre McGill, Executive General Manager, At Home Support, Bolton Clarke
– Ann Van Leerdam, Connect Local Community Connector, Bolton Clarke
– Dr Rajna Ogrin, Senior Research Fellow, Bolton Clarke Research Institute, Bolton Clarke - Dr Daniel Fineberg, Deputy Director General Medicine, Alfred Hospital, Victoria -
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.
